Tag: Mylan
Auvi-Q Takes Center Stage at School Nurse Conference
One example of the changing market dynamics for epinephrine auto-injectors in light of recent developments.
Welcome Symjepi™: Adamis’ Prefilled Epinephrine Syringe Receives FDA Approval
The additional competition should help lower costs across the emergency epinephrine market.
Mylan’s Chairman Was Paid $97.6 Million
Despite 2016 being a year when everything seemed to implode for the marketer of EpiPen.
Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy
More legal troubles for the embattled marketer of EpiPen.
Kmart Announces Lower Price of Adrenaclick Generic
May cost as low as $0 to consumers with commercial health insurance.
A Deeper Look Into the Racketeering Lawsuit Against Mylan
The suit exposes a convoluted system that works to our detriment.
Mylan Issues EpiPen Recall for the United States
Please note this important recall and follow the instructions if you are affected.
EpiPen Recalled in Australia
The recall is currently for Australia only.
A Tale of Two Countries: Half of UK Kids Prescribed Epinephrine May Not Have...
Epinephrine in the US is expensive. How is it that UK children are practically "swimming" in it?
Study: Anaphylaxis More Than Twice as Likely in the Classroom as Cafeteria
Indications are that many schools do not have staff permitted to administer epinephrine they have on-hand.
